Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Abstract
The BCL-2 protein family determines the commitment of cells to apoptosis, an ancient cell suicide programme that is essential for development, tissue homeostasis and immunity. Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischaemic conditions and drive neurodegeneration. We discuss the biochemical, structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold. These mechanistic insights into the functions of the BCL-2 family are illuminating the physiological control of apoptosis, the pathological consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Together with BOK, BCL2 family apoptosis regulator (BOK) [47], BAX and BAK are the only BCL2 family members characterized so far in mammalian cells for their ability to form pores across the outer mitochondrial membrane (OMM) and possibly other intracellular membranes [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“which is controlled by pro-apoptotic and anti-apoptotic members of the BCL2, apoptosis regulator (BCL2) protein family, a group of proteins sharing one to four BCL2 homology (BH) domains (i.e., BH1, BH2, BH3, and BH4) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Intrinsic apoptosis is a form of RCD initiated by a variety of microenvironmental perturbations including (but not limited to) growth factor withdrawal, DNA damage, endoplasmic reticulum (ER) stress, reactive oxygen species (ROS) overload, replication stress, microtubular alterations or mitotic defects [29–34].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“MOMP is antagonized by anti-apoptotic members of the BCL2 family, including BCL2 itself, BCL2 like 1 (BCL2L1; best known as BCL-XL), MCL1, BCL2 family apoptosis regulator (MCL1), BCL2 like 2 (BCL2L2; best known as BCL-W), and BCL2 related protein A1 (BCL2A1; best known—in human—as BFL-1) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Thus, most pro-survival BCL2 family members inhibit BAX and BAK by preventing their oligomerization and pore-forming activity either directly, upon physical sequestration at the OMM, or indirectly, following the sequestration of BH3-only activators [29, 64, 79, 110].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,679
Self-citationThe landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Self-citation
Cited by
Items 601–700 of 1,008
Mechanical Regulation of Apoptosis in the Cardiovascular System
Goldblatt, Z. E., Cirka, H. A., & Billiar, K. L. (2020) · Annals of Biomedical Engineering · doi:10.1007/s10439-020-02659-x · Cited by 57
Mitochondrial outer membrane permeabilization at the single molecule level
Dadsena, S., Jenner, A., & García‐Sáez, A. J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03771-4 · Cited by 62
“In the intrinsic pathway, diverse apoptotic stimuli convey death signals to mitochondria [16, 97] eventually resulting in the release of soluble proteins like cytochrome c and Second mitochondria-derived activator of caspase (Smac) from the mitochondrial intermembrane space (IMS) to the cytosol as a consequence of MOM…”
BackgroundSALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance
Sun, B., Xu, L., Bi, W., & Ou, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042053 · Cited by 58
“Overexpression of antiapoptotic Bcl-2 inhibits cell apoptosis and leads to an imbalance between enhanced proliferation and weakened programmed death through downregulation of Bax [73,74].”
BackgroundInfluentialPulya, S., Patel, T. K., Paul, M., Adhikari, N., Banerjee, S., Routholla, G., Biswas, S., Jha, T., & Ghosh, B. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114470 · Cited by 56
Membrane damage and repair: a thin line between life and death
Barisch, C., Holthuis, J. C. M., & Cosentino, K. (2023) · Biological Chemistry · doi:10.1515/hsz-2022-0321 · Cited by 60
Yi, J.-M., Zhang, X., Huan, X., Song, S., Wang, W., Tian, Q.-T., Sun, Y.-M., Chen, Y., Ding, J., Wang, Y.-Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3264 · Cited by 53
BH4 domain of Bcl-2 as a novel target for cancer therapy
Liu, Z., Wild, C., Ding, Y., Ye, N., Chen, H., Wold, E. A., & Zhou, J. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.11.008 · Cited by 66
Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies
Adams, C. M., Hiebert, S. W., & Eischen, C. M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1751 · Cited by 53
“Inhibiting Bcl-2 and/or Bcl-xL reportedly kills malignant hematopoietic cells, including lines we evaluated (23).”
Yuan, Y., Wang, Y., Hu, F. F., Jiang, C. Y., Zhang, Y. J., Yang, J., Zhao, S. W., Gu, J. H., Liu, X. Z., Bian, J. C., et al. (2016) · PubMed · doi:10.3967/bes2016.013 · Cited by 53
D’Orsi, B., Engel, T., Pfeiffer, S., Nandi, S., Kaufmann, T., Henshall, D. C., & Prehn, J. H. M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3780-15.2016 · Cited by 57
“The latter are further divided into Bcl-2 homology 3 (BH3)-only and Bax-like proteins (Czabotar et al., 2014).”
BackgroundWatson, E. C., Koenig, M. N., Grant, Z. L., Whitehead, L., Trounson, E., Dewson, G., & Coultas, L. (2016) · Development · doi:10.1242/dev.137513 · Cited by 53
“Apoptosis is a form of cell death responsible for the removal of excessive, damaged and otherwise redundant cells and tissues from the body (Czabotar et al., 2014).”
BackgroundBlockade of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin
Chen, Q., Meng, Y.-Q., Xu, X.-F., & Gu, J. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000529 · Cited by 54
Catalpol inhibits migration and induces apoptosis in gastric cancer cells and in athymic nude mice
Wang, Z.-H., & Hu, Z. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.094 · Cited by 57
Romagnoli, R., Prencipe, F., Oliva, P., Baraldi, S., Baraldi, P. G., Schiaffino‐Ortega, S., Chayah, M., Salvador, M. K., Lopez-Cara, L. C., Brancale, A., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01391 · Cited by 57
Park, S., Ko, W., Lee, H. S., & Shin, I. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b10098 · Cited by 57
Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
Läsche, M., Emons, G., & Gründker, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00409 · Cited by 57
Ye, Q., Zhou, Y., Zhao, C., Xu, L., & Jian, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.677810 · Cited by 53
“Bcl-2 family is divided into 3 categories on the basis of function and structure: BH3, the apoptosis initiator; the antiapoptotic guardians, such as Bcl-2; and the proapoptotic proteins, such as Bax and Bak (Czabotar et al., 2014).”
BackgroundPosttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology
Gonçalves, V., & Jordan, P. (2015) · BioMed Research International · doi:10.1155/2015/287048 · Cited by 64
“The Bcl-2 family comprises both proapoptotic and antiapoptotic proteins, depending on their BH domain composition, and it is the balance between both types of proteins that determines whether the mitochondrial pathway to apoptosis is activated [80].”
BackgroundA paired comparison between glioblastoma “stem cells” and differentiated cells
Schneider, M., Ströbele, S., Nonnenmacher, L., Siegelin, M. D., Tepper, M., Stroh, S., Hasslacher, S., Enzenmüller, S., Strauss, G., Baumann, B., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.29908 · Cited by 51
“These proteins are key mediators of treatment-induced apoptosis(35) and their pharmacological targeting is considered a promising therapeutic approach.(36) DCs express both lower amounts of proapoptotic BCL2 proteins (Fig.”
BackgroundLiu, F., Jiang, Y., Zhao, H., Yao, L., & Chen, L. (2015) · Acupuncture in Medicine · doi:10.1136/acupmed-2014-010728 · Cited by 54
Cell death and thymic tolerance
Daley, S. R., Teh, C. E., Hu, D. Y., Strasser, A., & Gray, D. H. D. (2017) · Immunological Reviews · doi:10.1111/imr.12532 · Cited by 56
Self-citationHseu, Y., Tsai, T.-J., Korivi, M., Liu, J.-Y., Chen, H.-J., Lin, C.-M., Shen, Y.-C., & Yang, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-08659-7 · Cited by 54
Regulation of Mcl-1 alternative splicing by hnRNP F, H1 and K in breast cancer cells
Tyson-Capper, A. J., & Gautrey, H. (2018) · RNA Biology · doi:10.1080/15476286.2018.1551692 · Cited by 56
Yuan, Y., Jiang, N., Li, Z., Song, Z., Yang, Z., Xue, W., Zhang, X., & Du, Y. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s194961 · Cited by 56
Zheng, J., Akbari, M., Schirmer, C., Reynaert, M.-L., Loyens, A., Lefebvre, B., Buée, L., Croteau, D. L., Galas, M.-C., & Bohr, V. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00896-8 · Cited by 52
He, Y., & Wang, X. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-922 · Cited by 57
“Notably, both Caspase-7 (33) and Bcl-2 (34) are involved in the apoptosis pathway which has been positively associated with antitumor immune signatures in cancer (35).”
InfluentialIcariin improves the cognitive function of APP/PS1 mice via suppressing endoplasmic reticulum stress
Li, F., Zhang, Y., Lu, X., Shi, J., & Gong, Q. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116739 · Cited by 51
Pro-apoptotic Bax molecules densely populate the edges of membrane pores
Kuwana, T., Olson, N. H., Kiosses, W. B., Peters, B., & Newmeyer, D. D. (2016) · Scientific Reports · doi:10.1038/srep27299 · Cited by 56
Meng, Z., Liu, Y., Wang, J., Fan, H., Fang, H., Li, S., Yuan, L., Liu, C., Peng, Y., Zhao, W., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29008 · Cited by 51
Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer
Westaby, D., Jiménez‐Vacas, J. M., Padilha, A., Varkaris, A. S., Balk, S. P., Bono, J. S. D., & Sharp, A. (2021) · Cancers · doi:10.3390/cancers14010051 · Cited by 67
“Of note, BH3-only protei s have varying binding affinities for different anti-apoptotic proteins, as they also do with pro-apoptotic ‘effector’ proteins [74].”
BackgroundMoujalled, D., Southon, A. G., Saleh, E., Brinkmann, K., Ke, F., Iliopoulos, M., Cross, R. S., Jenkins, M. R., Nhu, D., Wang, Z., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00977-2 · Cited by 60
“The binding of BH3-only proteins to the anti-apoptotic BCL-2 proteins frees BAX and BAK, the effectors of apoptosis, from their restraint by the anti-apoptotic BCL-2 proteins, thereby unleashing the caspase cascade that dismantles the dying cells [4, 5, 8].”
BackgroundSelf-citationGuo, Y., Xue, H., Hu, N., Liu, Y., Sun, H., Yu, D., Qin, L., Shi, G., Wang, F., Xin, L., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00027 · Cited by 57
Aneknan, P., Kukongviriyapan, V., Prawan, A., Kongpetch, S., Sripa, B., & Senggunprai, L. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.12.5071 · Cited by 52
“In this study, pronounced apoptotic cells found in CCA cells treated with luteolin were accompanied with the decrease in Bcl-2 protein expression.”
InfluentialGreenberg, E. F., McColl, K. S., Zhong, F., Wildey, G., Dowlati, A., & Distelhorst, C. W. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.355 · Cited by 51
“This approach has been reviewed in detail.(14,15,16) Among BH3-mimetic agents advancing through clinical trials for both hematological malignancies(15,17) and solid tumors(18) are ABT-737 and its orally bioavailable derivative ABT-263 (Navitoclax).”
BackgroundYao, J., Wei, X., & Lü, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.141 · Cited by 51
Li, H., Li, X., Bai, M., Suo, Y., Zhang, G., & Cao, X. (2015) · PubMed · Cited by 60
Jiang, S., Wang, Q., Feng, M., Li, J., Guan, Z.-B., An, D., Dong, M., Peng, Y., Kuerban, K., & Ye, L. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7930-9 · Cited by 51
“In addition , we also detected the presence of Bcl-2 family proteins , which have close association with caspases such as Bax, Bcl-2, and cytochrome c.”
InfluentialNecroptosis in amyotrophic lateral sclerosis and other neurological disorders
Morrice, J. R., Gregory, C. Y., & Shaw, C. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.025 · Cited by 59
Srivastava, R., Faust, T. E., Ramos, A., Ishizuka, K., & Sawa, A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.007 · Cited by 53
T Cells and Regulated Cell Death
Spetz, J. K. E., Presser, A. G., & Sarosiek, K. A. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.07.004 · Cited by 57
Ku, Y., Chan, V. S., Christesen, A. C., Grieme, T., Mulhern, M. M., Pu, Y., & Wendt, M. D. (2019) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b02750 · Cited by 51
MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities
Bisso, A., Sabò, A., & Amati, B. B. (2019) · Immunological Reviews · doi:10.1111/imr.12734 · Cited by 57
de Carvalho, J. T. G., Baldivia, D. D. S., Leite, D. F., de Araújo, L. C. A., Espindola, P. P. D. T., Antunes, K. Á., da Rocha, P. D. S., Souza, K. D. P., & dos Santos, E. L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3685264 · Cited by 57
“Moreover, ROS cause mitochondrial membrane depolarization and/or open Bax/Bak channels on the mitochondrial membrane, which allows for the release of apoptosis-inducing factor, endonuclease G, cytochrome c, and Smac/Diablo into the cytosol [72, 124].”
Hu, G., Chen, Y., Xie, P., Cao, Y., Shao, J., & Ge, J. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112152 · Cited by 54
Aging and Mesenchymal Stem Cells: Therapeutic Opportunities and Challenges in the Older Group
Chen, H., Liu, O., Chen, S., & Zhou, Y. (2021) · Gerontology · doi:10.1159/000516668 · Cited by 56
BCL-2 system analysis identifies high-risk colorectal cancer patients
Lindner, A. U., Salvucci, M., Morgan, C., Monsefi, N., Resler, A. J., Cremona, M., Curry, S., Toomey, S., O'Byrne, R., Bacon, O., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312287 · Cited by 50
Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinoma
Yi, H., Qiu, M., Yuan, L., Luo, Q., Pan, W., Zhou, S., Zhang, L., Yan, X., & Yang, D. (2020) · Cancer Medicine · doi:10.1002/cam4.3090 · Cited by 50
1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design
Faheem, F., Kumar, B. K., Sekhar, K. V. G. C., Chander, S., Kunjiappan, S., & Murugesan, S. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1916464 · Cited by 55
“The regulatory interplay between these two groups of proteins is fundamental for maintaining the balance between cell survival and cell death [64].”
BackgroundDiosgenin: Chemistry, extraction, quantification and health benefits
Arya, P., Munshi, M., & Kumar, P. (2022) · Food Chemistry Advances · doi:10.1016/j.focha.2022.100170 · Cited by 63
CCR9–CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway
Li, B., Wang, Z., Zhong, Y., Lan, J. X., Li, X., & Lin, H. (2015) · Medical Oncology · doi:10.1007/s12032-015-0531-0 · Cited by 50
Vaccinia Virus Protein A49 Is an Unexpected Member of the B-cell Lymphoma (Bcl)-2 Protein Family
Neidel, S., de Motes, C. M., Mansur, D. S., Strnadova, P., Smith, G. L., & Graham, S. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624650 · Cited by 50
“Unlike M11, A49 Does Not Bind Effector BH3 Peptides—A characteristic feature of antiapoptotic Bcl-2-like proteins is their ability to bind amphipathic BH3 peptides via a hydrophobic surface groove delineated by helices 2, 3, 4, and 5 (17).”
BackgroundInfluentialMacrophage cell death in microbial infections
Chow, S. H., Deo, P., & Naderer, T. (2016) · Cellular Microbiology · doi:10.1111/cmi.12573 · Cited by 58
Zou, Y., Li, Q., Jiang, L., Guo, C., Li, Y., Yu, Y., Li, Y., Duan, J., & Sun, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158475 · Cited by 50
Kuehl, T., & Lagares, D. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.020 · Cited by 50
“family of proteins is the expression of one or more conserved BCL-2 homology (BH) domains, named BH1, BH2, BH3 and BH4 [45] (Figure 1B).”
BackgroundWatanabe, D., Nogami, A., Okada, K., Akiyama, H., Umezawa, Y., & Miura, O. (2019) · Cancers · doi:10.3390/cancers11121827 · Cited by 50
“RSK1 was previously shown in IL-3-dependent model cell lines to mediate the MEK/ERK pathway cell survival signal through phosphorylation of Bad on S112 in mice [48], which abrogates its pro-apoptotic function by promoting its dissociation from the anti-apoptotic Bcl-2 family members [10].”
BackgroundSwitchable Aromatic Nanopore Structures: Functions and Applications
Sun, M., & Lee, M. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00254 · Cited by 52
Bioinspired Artificial Liver System with hiPSC‐Derived Hepatocytes for Acute Liver Failure Treatment
Wang, J., Ren, H., Liu, Y., Sun, L., Zhang, Z., Zhao, Y., & Shi, X. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101580 · Cited by 49
Zhang, Q., Zhao, X., Zhang, C., Wang, W., Li, F., Liu, D., Wu, K., Zhu, D., Liu, S., Shen, C., et al. (2019) · Cancer Management and Research · doi:10.2147/cmar.s214243 · Cited by 52
Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents
Wang, C., Zhang, Y., Shi, L., Yang, S., Chang, J., Zhong, Y., Li, Q., & Xing, D. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2074414 · Cited by 47
Molecular mechanisms and therapeutic potential of icariin in the treatment of Alzheimer's disease
Zheng, L., Wu, S., Jin, H., Wu, J., Wang, X., Cao, Y., Zhou, Z., Jiang, Y., Li, L., Yang, X., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154890 · Cited by 49
Large-scale exome sequence analysis identifies sex- and age-specific determinants of obesity
Kaisinger, L. R., Kentistou, K. A., Stankovic, S., Gardner, E. J., Day, F. R., Zhao, Y., Mörseburg, A., Carnie, C. J., Zagnoli-Vieira, G., Puddu, F., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100362 · Cited by 56
Deletion of Cyclophilin D Impairs β-Oxidation and Promotes Glucose Metabolism
Tavecchio, M., Lisanti, S., Bennett, M. J., Languino, L. R., & Altieri, D. C. (2015) · Scientific Reports · doi:10.1038/srep15981 · Cited by 54
Yun, M., Kim, E. O., Lee, D., Kim, J., Kim, J. K., Lee, H., Lee, J., & Kim, S. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366305 · Cited by 49
Chang, C.-T., Korivi, M., Huang, H., Thiyagarajan, V., Lin, K., Huang, P.-J., Liu, J.-Y., Hseu, Y., & Yang, H. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.02.019 · Cited by 49
Potential Toxicity of Polymyxins in Human Lung Epithelial Cells
Ahmed, M. U., Velkov, T., Lin, Y., Yun, B., Nowell, C. J., Zhou, F., Zhou, Q. T., Chan, K. H., Azad, M. A. K., & Li, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02690-16 · Cited by 51
“It has been reported that death receptor-activated caspase 8 may propagate apoptotic signals by activating downstream caspases or causing the release of cytochrome c from mitochondria, thereby triggering the mitochondrial pathway through the activation of caspase 9 (42).”
BackgroundLiao, Y., Wang, H.-X., Mao, X., Wang, H., Wang, H., Li, Y., Sun, Y., Song, C., Tan, L., Ding, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17970 · Cited by 49
“Caspase 9 in turn cleaves and activates caspase 3, leading to apoptosis [20, 21].”
BackgroundHuang, Q., Li, S., Cheng, P., Deng, M., He, X., Wang, Z., Yang, C., Zhao, X., & Huang, J. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i27.5018 · Cited by 54
Chen, G., Wang, K., Wu, P., Wang, Y., Zhou, Z., Yin, L., Sun, M., & Oupický, D. (2017) · Nano Research · doi:10.1007/s12274-017-1946-z · Cited by 49
Lucantoni, F., Lindner, A. U., O’Donovan, N., Düßmann, H., & Prehn, J. H. M. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0039-y · Cited by 53
Abdoul-Azize, S., Buquet, C., Li, H., Picquenot, J.-M., & Vannier, J.-P. (2018) · Oncogene · doi:10.1038/s41388-018-0329-6 · Cited by 39
Lucantoni, F., Düßmann, H., Llorente‐Folch, I., & Prehn, J. H. M. (2018) · Oncotarget · doi:10.18632/oncotarget.25433 · Cited by 50
“Proteins of the BCL2 family control the process of mitochondrial outer membrane permeabilization (MOMP) during apoptosis [11].”
BackgroundEnsemble Properties of Bax Determine Its Function
Robin, A. Y., Iyer, S., Birkinshaw, R. W., Sandow, J. J., Wardak, A. Z., Luo, C. S., Shi, M. X., Webb, A. I., Czabotar, P. E., Kluck, R. M., et al. (2018) · Structure · doi:10.1016/j.str.2018.07.006 · Cited by 50
Self-citationToward Targeting Antiapoptotic MCL-1 for Cancer Therapy
Kelly, G. L., & Strasser, A. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033510 · Cited by 50
“Apoptotic cell death is regulated by three subsets of proteins of the BCL-2 family (Figure 1) (Czabotar et al. 2014,Green 2019,Singh et al. 2019).”
BackgroundSelf-citationDiscovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent
Lü, X., Liu, Y., Orvig, C., Liang, H., & Chen, Z. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02047 · Cited by 52
Han, S., Wang, Y., Ma, J., Wang, Z., Wang, H., & Yuan, Q. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02859-2 · Cited by 54
Guttà, C., Rahman, A., Aura, C. M., Dynoodt, P., Charles, E. M., Hirschenhahn, E., Joseph, J., Wouters, J., de Chaumont, C., Rafferty, M., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2309-3 · Cited by 54
Anti-cancer effect of boron derivatives on small-cell lung cancer
Cebeci, E., Yüksel, B., & Şahi̇n, F. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.126923 · Cited by 48
Narmani, A., Ganji, S., Amirishoar, M., Jahedi, R., Kharazmi, M. S., & Jafari, S. M. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125554 · Cited by 49
Fu, M., Wan, F., Li, Z., & Zhang, F. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.030 · Cited by 50
Park, E., Chauhan, A. K., Min, K., Park, D. C., & Kwon, T. K. (2016) · Oncology Reports · doi:10.3892/or.2016.5019 · Cited by 49
Bcl-2 delays cell cycle through mitochondrial ATP and ROS
Du, X., Fu, X., Yao, K., Lan, Z., Xu, H., Cui, Q., & Yang, E. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1295182 · Cited by 50
“As a target gene in cancer therapy, Bcl-2 was intensively studied in recent decades.(8,9) However, the”
BackgroundHe, S., Liu, H., Zhou, Y., & Yue, Q. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.026 · Cited by 48
Lin, C., Gu, J., Wang, H., Zhou, J., Li, J., Wang, S., Jin, Y., Liu, C., Liu, J., Yang, H., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00238-18 · Cited by 50
Turning On/Off the Anti-Tumor Effect of the Au Cluster via Atomically Controlling Its Molecular Size
Zhai, J., Jia, Y., Zhao, L., Yuan, Q., Gao, F., Zhang, X., Cai, P., Gao, L., Guo, J., Yi, S., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b00027 · Cited by 48
Yu, M., Liu, T., Chen, Y.-C., Li, Y., & Li, W. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0779-2 · Cited by 51
“Bcl-2-family proteins play a role in chemotherapy induced cell death, including apoptosis and autophagy [39].”
De novo coiled-coil peptides as scaffolds for disrupting protein–protein interactions
Fletcher, J. M., Horner, K. A., Bartlett, G. J., Rhys, G. G., Wilson, A. J., & Woolfson, D. N. (2018) · Chemical Science · doi:10.1039/c8sc02643b · Cited by 51
Cheng, J., Qian, D., Ding, X., Song, T., Cai, M., Xie, D., Wang, Y., Zhao, J., Liu, Z., Wu, Z., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1017-8 · Cited by 53
Xue, Y., Sun, C., Hao, Q., & Cheng, J. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1595-0 · Cited by 48
RetractedThe Role of Inhibition of Apoptosis in Acute Leukemias and Myelodysplastic Syndrome
McBride, A., Houtmann, S., Wilde, L. R., Vigil, C. E., Eischen, C. M., Kasner, M. T., & Palmisiano, N. D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00192 · Cited by 53
Cell Death in Cells Overlying Lateral Root Primordia Facilitates Organ Growth in Arabidopsis
Escamez, S., André, D., Sztojka, B., Bollhöner, B., Hall, H., Berthet, B., Voß, U., Lers, A., Maizel, A., Andersson, M. J., et al. (2020) · Current Biology · doi:10.1016/j.cub.2019.11.078 · Cited by 49
Blake, D., & Lynch, K. W. (2021) · Immunological Reviews · doi:10.1111/imr.13018 · Cited by 52
Lucantoni, F., Dussmann, H., & Prehn, J. H. M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00113 · Cited by 47
Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia
Saliba, A. N., John, A. J., & Kaufmann, S. H. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.95 · Cited by 57
“These are in turn neutralized when they are bound and sequestered by the anti-apoptotic paralogs BCL2, BCLXL, MCL1, BCLW, BCLB, and BFL1[110–113].”
BackgroundInfluentialWang, Z., Hu, H., Heitink, L., Rogers, K., You, Y., Tan, T., Suen, C. L. W., Garnham, A., Chen, H., Lieschke, E., et al. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01122-3 · Cited by 46
“This demonstrates that apoptosis is not required for APR-246 induced killing in these two cancer cell lines.”
Self-citationPathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · Biomedicines · doi:10.3390/biomedicines11041166 · Cited by 58
Lin, L., Sun, B., Hu, Y., Yang, W., Li, J., Wang, D., Zhang, L., Lu, M., Li, Y., Li, Y., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70032 · Cited by 51
Bh3 induced conformational changes in Bcl‐Xl revealed by crystal structure and comparative analysis
Rajan, S., Choi, M., Baek, K., & Yoon, H. S. (2015) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.24816 · Cited by 47
Bai, J., Lei, Y., An, G., & He, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121247 · Cited by 49
“Therefore, Bcl-2 family proteins and cytochrome c are considered apoptotic regulators that represent a vital checkpoint within apoptotic pathways [22].”
BackgroundThe effect of caffeine on cisplatin-induced apoptosis of lung cancer cells
Wang, G., Bhoopalan, V., Wang, D., Wang, L., & Xu, X. (2015) · Experimental Hematology and Oncology · doi:10.1186/2162-3619-4-5 · Cited by 48
“PUMA, three important proteins involved in the DNA damage-induced apoptosis process [14], in both untreated and cisplatin/caffeine-treated HTB182 and CRL5985 lung cancer cells (Figure 3).”
BackgroundBarile, E., Marconi, G. D., De, S. K., Baggio, C., Gambini, L., Salem, A. F., Kashyap, M. K., Castro, J. E., Kipps, T. J., & Pellecchia, M. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00962 · Cited by 49
Metadata
- Authors
- Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M.
- Affiliations
- The University of Melbourne (AU)
- Corresponding author
- Strasser, Andreas
- Adams, Jerry M.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2013-12-20
- Volume
- 15
- Issue
- 1
- Pages
- 49-63
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2088883749
- Cited by
- 3,219
- References
- 218
- Citations by year
- 2026: 164 · 2025: 220 · 2024: 249 · 2023: 230 · 2022: 265 · 2021: 319 · 2020: 299 · 2019: 285 · 2018: 314 · 2017: 292 · 2016: 287 · 2015: 209 · 2014: 77 · 2013: 1
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bcl-2 family proteins, apoptosis, mitochondrial outer membrane, BCL-2 inhibitor, cancer therapy, autoimmune disease, neurodegeneration, ischemia, apoptosis regulation
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Models, Molecular, Molecular Sequence Data, Neoplasms, Signal Transduction, Apoptosis, Protein Structure, Secondary, Proto-Oncogene Proteins c-bcl-2, Apoptosis Regulatory Proteins, Protein Multimerization, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.